Secondary Carcinoma — Trials

Secondary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

222 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 75
Recruiting: 42
Ph III recruiting: 2
Growth YoY: —
Industry share: 4%
Top sponsor: Guangzhou Medical University
Termination share: 26%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 51–57 of 57 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03507244	Concurrent Intrathecal-pemetrexed and Involved-field Radiotherapy for Leptomeningeal Metastasis From Solid Tumors	completed	Phase 1 / Phase 2	34	The First Hospital of Jilin UniversityOTHER	1	Dec 26, 2019	clinicaltrials
NCT03699332	Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origin(MMIPC)	unknown	Phase 1 / Phase 2	29	Radboud University Medical CenterOTHER	1	Sep 13, 2019